Skip to content

Alzheimer's Disease Health Center

Font Size

Alzheimer's Cure Elusive Despite Progress

Ronald Reagan's struggle shows how far we've come, how far we have to go.

Tomorrow's Plaque Fighters

Gandy says that scientists are in hot pursuit of three anti-amyloid ideas.

First is the anti-plaque antibody approach. Using a vaccine and allowing the body to make antibodies seems too dangerous. But what if you could raise plaque-busting antibodies in the laboratory? Theoretically, you then could find a dose that cuts plaque without killing the patient.

This isn't science fiction any more. Several companies are racing to develop this strategy, known as passive immunization or passive antibody transfer.

"It works in the mouse model," Gandy says. "It should be effective."

The second idea is to keep plaque from forming clumps. Amyloid gets particularly sticky when it combined with two substances: sugars and metals (especially zinc). Drugs that block both of these combinations are in the pipeline. And they work in mice, Gandy says.

The third idea -- and the one closest to reality -- involves new uses for existing drugs. Amyloid doesn't just happen. It's the result of a complex biochemical process. The process stops without a key set of enzymes.

It's recently become clear that some of the cholesterol-fighting drugs called statins block these enzymes. Data from trials of one of these drugs -- Lipitor -- suggest that people taking the drug to treat high cholesterol have a lower risk of Alzheimer's disease. The National Institute on Aging (NIA) is conducting a large clinical trial to see whether another of these drugs, Zocor, actually prevents Alzheimer's.

The NIA is also looking at another class of drugs capable of blocking amyloid production. It's the NSAIDs or nonsteroidal anti-inflammatory drugs -- the same class to which aspirin and ibuprofen belong. One of these drugs, Ansaid, may be particularly effective against amyloid, Gandy says.

If these drugs already exist, why aren't they being used? The reason is that amyloid plaques are notoriously hard to detect until Alzheimer's disease is well under way.

That, too, is changing. Gandy says that new imaging techniques called PET scans will allow doctors to see tiny spots of amyloid.

"This might be useful for very early diagnosis of people getting Alzheimer's disease, decades before symptoms show up," Gandy says. "And it will help with developing prevention drugs, because it will let you see what is going on."

Many people who don't think plaque is the No. 1 bad guy have another villain in mind. These are the tangled fibers in the brains of Alzheimer's patients. It's been hard to work on anti-tangle drugs, because there's no good animal model. But progress is being made, Gandy says.

Today on WebMD

Remember your finger
When it’s more than just forgetfulness.
senior man with serious expression
Which kinds are treatable?
senior man
Common symptoms to look for.
mri scan of human brain
Can drinking red wine reverse the disease?
senior man
daughter and father
Making Diagnosis
Colored mri of brain
Close up of elderly couple holding hands
mature woman
Woman comforting ailing mother
Senior woman with serious expression